WebTable 1, Statin Dosing and ACC/AHA Classification of Intensity - Statin ... WebTo compare the efficacy of different statin treatments by intensity on levels of non-high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular disease in people with diabetes. ... BMJ 2024;376:e067731 doi: 10.1136/bmj-2024-067731 3 cegorisation of statin intensityat
Appendix A: Grouping of statins Cardiovascular disease: risk ...
WebOct 21, 2024 · A moderate-intensity statin is recommended. And for those with multiple risk factors, consideration should be given to high-intensity statin to reduce LDL-C by ≥50%. In persons with ASCVD, the LDL-C should be reduced by ≥50% with the highest tolerated dose of high-intensity statin. If LDL remains >70 mg/dl, it is reasonable to add ezetimibe. WebAug 23, 2024 · August 23, 2024. Recommendations made by the USPSTF are independent of the U.S. government. ... initiate a moderate-intensity statin after discussing the rationale and provided the patient agrees. In patients who have a cardiovascular risk factor and an estimated 10-year CVD risk of 7.5% to less than 10%, the benefit of starting a statin is ... hell\\u0027s kitchen season 8 contestant dies
Lipid Management for Prevention of ASCVD
WebAug 25, 2024 · High-intensity statin should be considered in those patients with 10-year risk >7.5% or with diabetes-specific risk enhancers. If patients with diabetes have 10-year ASCVD risk >20% and there is <50% reduction in LDL-C and/or LDL-C >70 mg/dL (or non–HDL-C >100 mg/dL) on maximally tolerated statin therapy, they may be considered for the ... WebJan 19, 2024 · Statins can be placed into three different categories based on how much they can lower LDL: Low intensity statins: these can lower LDL by no more than 30%. Moderate … WebThis calculator estimates atherosclerotic cardiovascular disease (ASCVD) risk and provides management strategies for patients ages 40 to 75 years with LDL levels >70 and <190 mg/dL. Risk is calculated using logic from the 10-year Multi-Ethnic Study of Atherosclerosis (MESA), ASCVD pooled cohort risk equations, and Framingham 30-year ASCVD risk. hell\u0027s kitchen season 8 episode 12